X0306 4 2018-10-25 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001191818 LEFKOFF KYLE C/O BOULDER VENTURES 1941 PEARL STREET, SUITE 300 BOULDER CO 80302 true false false false Common Stock 2018-10-26 4 M false 5000.00 A 22720.00 D Common Stock 45000.00 I See footnote Stock Option (Right to Buy) 14.55 2018-10-25 4 A false 25000.00 0.00 A 2028-10-25 Common Stock 25000.00 25000.00 D Restricted Stock Units 0.00 2018-10-25 4 A false 5000.00 0.00 A Common Stock 5000.00 5000.00 D Restricted Stock Units 0.00 2018-10-26 4 M false 5000.00 0.00 D Common Stock 5000.00 0.00 D Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by Array BioPharma Inc. ("Array") on October 26, 2017, as a result of the vesting of all such RSUs. Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff. The options vest in full on October 25, 2019, subject to continued service on Array's board of directors. RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors. The RSUs vested and were settled in common stock on October 26, 2018. Jason Haddock, attorney-in-fact for Kyle A. Lefkoff 2018-10-29